Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes
D Williams‐Herman, J Johnson, R Teng… - Diabetes, Obesity …, 2010 - Wiley Online Library
Aim: To assess the 104‐week efficacy and safety of sitagliptin and metformin as initial
combination therapy and as monotherapy in patients with type 2 diabetes and inadequate …
combination therapy and as monotherapy in patients with type 2 diabetes and inadequate …
Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes.
D Williams-Herman, J Johnson… - Diabetes, Obesity & …, 2010 - search.ebscohost.com
Aim: To assess the 104-week efficacy and safety of sitagliptin and metformin as initial
combination therapy and as monotherapy in patients with type 2 diabetes and inadequate …
combination therapy and as monotherapy in patients with type 2 diabetes and inadequate …
Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes
D Williams‐Herman, J Johnson, R Teng… - Diabetes, Obesity and …, 2010 - infona.pl
Aim: To assess the 104‐week efficacy and safety of sitagliptin and metformin as initial
combination therapy and as monotherapy in patients with type 2 diabetes and inadequate …
combination therapy and as monotherapy in patients with type 2 diabetes and inadequate …
[PDF][PDF] Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes
D Williams-Herman, J Johnson, R Teng… - Diabetes, Obesity and …, 2010 - osvepharma.com
Aim: To assess the 104-week efficacy and safety of sitagliptin and metformin as initial
combination therapy and as monotherapy in patients with type 2 diabetes and inadequate …
combination therapy and as monotherapy in patients with type 2 diabetes and inadequate …
Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes.
D Williams-Herman, J Johnson, R Teng… - Diabetes, Obesity & …, 2010 - europepmc.org
Aim To assess the 104-week efficacy and safety of sitagliptin and metformin as initial
combination therapy and as monotherapy in patients with type 2 diabetes and inadequate …
combination therapy and as monotherapy in patients with type 2 diabetes and inadequate …
Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes
D Williams-Herman, J Johnson, R Teng, G Golm… - 2010 - pubmed.ncbi.nlm.nih.gov
Aim To assess the 104-week efficacy and safety of sitagliptin and metformin as initial
combination therapy and as monotherapy in patients with type 2 diabetes and inadequate …
combination therapy and as monotherapy in patients with type 2 diabetes and inadequate …
[PDF][PDF] Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes
D Williams-Herman, J Johnson, R Teng… - Diabetes, Obesity and …, 2010 - academia.edu
Aim: To assess the 104-week efficacy and safety of sitagliptin and metformin as initial
combination therapy and as monotherapy in patients with type 2 diabetes and inadequate …
combination therapy and as monotherapy in patients with type 2 diabetes and inadequate …
Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes
D Williams‐Herman, J Johnson, R Teng… - Diabetes, Obesity and …, 2010 - cir.nii.ac.jp
抄録< jats: p>< jats: bold> Aim:</jats: bold> To assess the 104‐week efficacy and safety of
sitagliptin and metformin as initial combination therapy and as monotherapy in patients with …
sitagliptin and metformin as initial combination therapy and as monotherapy in patients with …